⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ROIV News
Roivant Sciences Ltd. Common Shares
JRM Construction Management Delivers Multi-Floor Headquarters for Roivant at One Penn Plaza
accessnewswire.com
ROIV
JAMA Dermatology Publishes Skin-Specific Outcomes from Phase 3 VALOR Trial Of Brepocitinib in Dermatomyositis
globenewswire.com
ROIV
Form 8-K
sec.gov
IMVT
ROIV
Form 8-K
sec.gov
ROIV
Priovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS)
globenewswire.com
ROIV
ROIVW
Roivant Reports Financial Results for the First Quarter Ended June 30, 2026, and Provides Business Update
globenewswire.com
ROIV
ROIVW
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
globenewswire.com
ROIV
IMVT
Priovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS)
globenewswire.com
ROIV
ROIVW
Roivant Reports Financial Results for the First Quarter Ended June 30, 2026, and Provides Business Update
globenewswire.com
ROIV
ROIVW
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
globenewswire.com
IMVT
ROIV